name: | Cabergoline | |
ATC code: | G02CB03 | route: | oral |
compartments: | 2 | |
dosage: | 1 | mg |
volume of distribution: | 173 | L |
clearance: | 3.6 | L/h |
other parameters in model implementation |
Cabergoline is a long-acting dopamine D2 receptor agonist used primarily for the treatment of hyperprolactinemia and disorders associated with prolactin excess. It is also sometimes used off-label for Parkinson's disease. Cabergoline is approved and in clinical use today.
Pharmacokinetic parameters reported in healthy adult volunteers of both sexes after oral administration.